Effects of two major activating lesions on the structure and conformation of human ras oncogene products. [PDF]
Proc Natl Acad Sci U S A, 1985 Srivastava SK +3 more
europepmc +1 more source
Factors associated with retention and viral suppression among a cohort of HIV+ women of color. [PDF]
AIDS Patient Care STDS, 2015 Blank AE +5 more
europepmc +1 more source
Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding. [PDF]
Proc Natl Acad Sci U S A, 1985 Clark R +4 more
europepmc +1 more source
Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells. [PDF]
Proc Natl Acad Sci U S A, 1984 Yuasa Y +6 more
europepmc +1 more source
Identification of the protein encoded by the human diffuse B-cell lymphoma (dbl) oncogene. [PDF]
Proc Natl Acad Sci U S A, 1986 Srivastava SK +3 more
europepmc +1 more source
A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. [PDF]
Proc Natl Acad Sci U S A, 1984 Kraus MH, Yuasa Y, Aaronson SA.
europepmc +1 more source
Transcription factor CUTL1 is a negative regulator of drug resistance in gastric cancer. [PDF]
J Biol Chem, 2013 Li T +12 more
europepmc +1 more source
Antibody of predetermined specificity to a carboxy-terminal region of H-ras gene products inhibits their guanine nucleotide-binding function. [PDF]
Mol Cell Biol, 1985 Srivastava SK +3 more
europepmc +1 more source
Preparation and characterization of antibodies against human ribosomal proteins: heterogeneous expression of S11 and S30 in a panel of human cancer cell lines. [PDF]
Jpn J Cancer Res, 2000 Nadano D +5 more
europepmc +1 more source
Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. [PDF]
Proc Natl Acad Sci U S A, 1986 Reynolds SH +4 more
europepmc +1 more source